An atypical junction of BCR-ABL gene as molelcular marker for quantitative monitoring of minimal residual disease in patients with chronic myeloid leukemia (CML)
Authors | |
---|---|
Year of publication | 2008 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Description | An atypical junction of BCR-ABL gene as molelcular marker for quantitative monitoring of minimal residual disease in patients with chronic myeloid leukemia (CML). |
Related projects: |